Table 2.
Randomized trials comparing ABVD or regimen of equivalent efficacy alone with treatment that includes RT
FFDP indicates freedom from disease progression; Tata, Tata Memorial Hospital, Mumbai; CCG, Children's Cancer Group; MSKCC, Memorial-Sloan Kettering Cancer Center; and NR, not reported.
*Includes stage I or II patients only.
†Includes group 1 patients only;
‡Control therapy.
